Masimo develops innovative noninvasive monitoring technologies for personal and professional health applications, including wearable devices and pulse oximeters. The technologies are used in both home and hospital settings.

Masimo

Masimo Personal Health

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Content Delivery Network

Chief Operating Officer

Bilal Muhsin

Founder and Clinical Director

Cindy Willis

Director Board of Directors

Craig Reynolds

Owner and General Manager

Doug Pousma

President, Consumer Health

Eugene Goldberg

Owner

Grace Chung

Engineering

Jason Tam

Co Founder

Jerry Novak

Founder, Chairman & CEO

Joe Kiani

President, Performance Brands Division (Denon, Polk, Definitive Technology, & Boston Acoustics)

Joel Sietsema

Michelle Brennan

Jack W. Lasersohn

interim CEO

Ed Cahill

Director

Anand Sampath

Director, Systems Engineering

Masoud Firouzi

Senior Software Engineer II

Franco Lodato

Lead Industrial Design - Luxury Products

Timothy Chuma

IS Manager EMEA

EVP Engineering

SEDLine is a research-focused company that aims to expand the scope and applications for neuromonitoring.

United States Medical Device Companies (Top 10K)

Private Equity Funded Companies (Top 10K)

United States Companies With More Than 500 Employees (Top 10K)

Health Care Companies With More Than 500 Employees (Top 10K)

Masimo Corporation, founded in 1989 and headquartered in Irvine, California, is a medical technology company that develops, manufactures, and markets innovative non-invasive patient monitoring measurements, sensors and devices, hospital automation and connectivity solutions, telehealth solutions, and consumer health and wellness devices.

Masimo is best known for its pulse oximetry technology, Masimo Signal Extraction Technology® (SET®) — which today is considered to be modern pulse oximetry. Masimo SET® addresses the limitations of conventional pulse oximetry, such as its poor performance during patient motion or low perfusion. Founder and CEO Joe Kiani was inspired to develop more reliable, accurate technology after observing ineffective pulse oximetry in the neonatal care unit (NICU). 

Masimo’s pulse oximetry is at the heart of many of its monitoring devices and products. In 2023, SET®’s origin — as a way to more reliably monitor NICU babies — came full circle with the introduction of Masimo Stork™, a baby monitor that uses SET® and other advanced technologies to help parents track their babies’ health indicators at home.

In addition to Masimo SET®, the company has developed numerous noninvasive measurements (collectively known as the rainbow SET® family of measurements), a suite of advanced devices like the Root® patient monitoring and connectivity platform, many other innovative bedside, handheld, and tetherless devices, and remote patient monitoring and management solutions like Masimo Patient SafetyNet™ and Masimo SafetyNet 

These devices and solutions help caregivers monitor numerous physiological parameters including blood oxygen saturation (SET® SpO2), total hemoglobin (SpHb®) carboxyhemoglobin (SpCO®), fluid responsiveness (PVi®), methemoglobin (SpMet), respiration rate from the pleth (RRp®), brain function while sedated (SedLine®), regional and cerebral oximetry (O3®), cardiac output (LiDCO™), end-tidal carbon dioxide and other capnography measurements (NomoLine®), acoustic respiratory rate (RRa®), and more. 

Masimo also develops therapeutic products like Masimo softFlow™ which delivers respiratory support to patients with spontaneous breathing. Additionally, Bridge™ by Masimo is a non-drug device that alleviates symptoms of opioid withdrawal through neuromodulation — making recovery safer and easier. Masimo also offers the first FDA-authorized device to alert users in the event of an opioid overdose, Opioid Halo™, and wearable devices like the Masimo W1™ advanced health tracking watch.

The company sells its products to end-users through direct sales and distributors, as well as to original equipment manufacturers (OEMs) and other partners to incorporate into their products.

Politan Capital Management

Post-IPO Equity - Masimo

Robeco

Bill & Melinda Gates Foundation

Grant - Masimo

Venture Round - Masimo

Irvine

California

United States

North America

Parent Tested Parent Approved unveils latest award-winning family products

Apple Continues Working to Get Blood Oxygen Sensing Back in U.S. Apple Watches as Next Masimo Trial Begins

Masimo Reports Third Quarter 2024 Financial Results

Here's How Much $1000 Invested In Masimo 10 Years Ago Would Be Worth Today

Masimo's claims falter as Apple defends smartwatch designs in court

Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand

News Highlights: Top Company News of the Day - Tuesday at 11 PM ET

News Highlights: Top Company News of the Day - Tuesday at 7 PM ET

News Highlights: Top Company News of the Day - Tuesday at 9 PM ET

Apple wins $250 in latest court clash with Masimo

Peru

South America

United Arab Emirates

Asia

Palestinian Territory

United Kingdom

Europe

HTML5

Lightbox

Google Analytics

Google Fonts

Vimeo

Cloudflare CDN

GoDaddy

jQuery

Adobe Flash

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

news impact assignment basic	general
public peers	general	Sep 28, 2024 5:37 PM	6fb8e4fb
news daily refresh	general	Dec 4, 2024 2:16 PM	4b77cc76
news processing daily refresh	general	Dec 5, 2024 3:38 AM	06918f94
news impact assignment daily	general
news processing basic	general	Dec 5, 2024 3:40 AM	7f3f5fef
company summary	general
signals	general	Sep 28, 2024 5:37 PM	ec799146
crunchbase trigger	general	Nov 22, 2024 7:44 AM	4a645086
crunchbase profile	general	Nov 22, 2024 10:33 AM	01790db6
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:22 PM	6caf342c
peers	general	Sep 28, 2024 5:37 PM	328109de
news basic	general	Dec 4, 2024 2:13 PM	b10a97cc
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MASIMO

Masimo

Last Close

169.12

22/11 21:00

Market Cap

5.69B

Beta: -

Volume Today

817.42K

Avg: -